A Pilot Study of Trauma-Focused Cognitive-Behavioral Therapy for Treatment of Post-traumatic Stress in Adults.
A Pilot Study of Feasibility and Acceptability of Videoconference-Delivered Trauma-Focused Cognitive Behavioral Therapy for Treatment of PTSD and C-PTSD in Adults of Community and Hospitals Mental Health Services
1 other identifier
interventional
13
1 country
5
Brief Summary
Post-traumatic stress disorder (PTSD) is a mental health condition that's triggered by the experience of potentially traumatic events. Complex PTSD (CPTSD) includes additional symptoms that account for a disturbance of the organization of the self. Randomized controlled trials have shown that trauma-focused cognitive behavioral therapy (TF-CBT) is effective in reducing PTSD symptoms; however, there is insufficient evidence to support the effectiveness of this intervention for CPTSD. The present study aims to evaluate the feasibility and acceptability of TF-CBT therapy for complex presentation (TF-CBT-CP) in a videoconference modality in adults diagnosed with PTSD or CPTSD who are treated at community mental health care services (CMHCS, COSAM in Spanish) and the Hospital of the Maule Region, Chile. This pilot study will use a mixed design. The quantitative component will consist of a one-group pre-post-follow-up design, which will include 13 adults diagnosed with PTSD or CPTSD referred to care at CMHCS or hospitals of the Maule Region, Chile. Telephone interviews will collect qualitative data relevant to the study's acceptability. Participants will receive TF-CBT-CP therapy. It consists of 16 weekly 60-minute sessions of trauma-focused cognitive behavioral therapy for complex presentations. To determine the feasibility of TF-CBT-CP therapy, eligibility, recruitment, participation, activity completion, retention, exit, and dropout rates will be considered. To establish the acceptability of the protocol, participant satisfaction with the recruitment, assessment, and treatment process and reporting of reasons for non-participation or dropout will be assessed. Furthermore, secondary outcomes consider the reduction of PTSD and CPTSD symptomatology, depression, and anxiety and the improvement of indicators of emotional regulation and psychological well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
Typical duration for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2024
CompletedFirst Posted
Study publicly available on registry
July 24, 2024
CompletedStudy Start
First participant enrolled
October 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
February 3, 2026
January 1, 2026
2.4 years
July 2, 2024
January 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Eligibility rate as a feasibility indicator
Proportion of patients who meet eligibility criteria compared to the total number of patients registered in the community mental health care services and hospital referral system during the recruitment period.
At the baseline assessment during the recruitment period.
Recruitment rate as a feasibility indicator.
The proportion of patients who accept the invitation to participate in the study with respect to those who meet the eligibility criteria.
At the baseline assessment during the recruitment period.
Participation rate in the evaluation protocol as a feasibility indicator.
Proportion of patients who fully conclude activities in all 3 assessments: initial evaluation, at week 16 after the start of treatment (or end of treatment), and follow-up at week 20 after the start of treatment, with respect to the total number of people who agree to participate in the study.
At baseline, 16-weeks and 20- week after the start of treatment.
Trauma-Focused Cognitive Behavioral Therapy for complex presentation (TF-CBT-CP) activities completion rate.
Percentage of participants who concluded all (100%) of the proposed activities in the 16 treatment sessions, as reported in the TF-CBT-CP patients' activities diary carried out inside or outside sessions.
During the intervention period.
Participants retention rate as a feasibility indicator.
Percentage of participants who remain in the study at weeks 16 and 20 after the start of treatment, respect to the total number of participants who started treatment.
When the intervention is finished at 16 weeks after the start of treatment and at follow-up measurement (20 weeks after the start of treatment).
Participants exit rate as a feasibility indicator.
Proportion of participants who meet study exit criteria at weeks 16 and 20 after the start of treatment, compared to the total number of participants who started treatment.
When the intervention is finished at 16-weeks after the start of treatment and at follow-up measurement (20 weeks after the start of treatment).
Participants attrition rate as a feasibility indicator.
Proportion of participants who drop out of the study at weeks 16 and 20 after the start of treatment, compared to the total number of participants who started treatment.
When the intervention is finished at 16 weeks after the start of treatment and at follow-up measurement (weeks after the start of treatment).
Qualitative description of the participants' acceptability as an acceptability indicator.
To obtain a qualitative description of participants' acceptability of the recruitment process, the assessment protocol (baseline, end-of-treatment, and follow-up assessment), and the treatment, semi-structured interviews will be conducted with participants, including questions related to acceptability of the study. The information collected will be recorded and summarized using thematic analysis guidelines.
At follow-up measurement (20 weeks after the start of treatment).
Reasons for study refusals as an acceptability indicator
A list of reasons given by patients who refused to participate in the study. We will aggregate the results as percentages.
During the recruitment period.
Reasons for study drop out as an acceptability indicator
A list of reasons given by patients who decided to drop-out the study. We will aggregate the results as percentages.
During treatment (between week 1 and week 16 after starting treatment) and follow-up (20 weeks after starting treatment)
Participant satisfaction as an acceptability indicator
Description of participant satisfaction level based on the Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 is a self-report scale of 8 items that evaluate patients' overall satisfaction with treatment through a Likert scale from 1 (low satisfaction) to 4 (high satisfaction); the higher the score, the higher the patients' satisfaction.
When the intervention is finished at 16 weeks after the start of treatment and at follow-up measurement (20 weeks after the start of treatment).
Secondary Outcomes (10)
Changes in PTSD symptoms, according to mean scores obtained with the International Trauma Questionnaire (ITQ).
At baseline, 16 weeks, and 20 weeks after the start of treatment.
Changes in CPTSD symptoms, according to mean scores obtained with the International Trauma Questionnaire (ITQ).
At baseline, 16 weeks, and 20 weeks after the start of treatment.
Changes in PTSD symptoms, according to mean scores obtained with the International Trauma Interview (ITI).
At baseline, 16 weeks, and 20 weeks after the start of treatment.
Changes in CPTSD symptoms, according to mean scores obtained with the International Trauma Interview (ITI).
At baseline, 16 weeks, and 20 weeks after the start of treatment.
Change in depressive symptoms according to mean scores obtained with the Patient Health Questionnaire (PHQ-9).
At baseline, 16 weeks, and 20 weeks after the start of treatment.
- +5 more secondary outcomes
Study Arms (1)
Trauma-Focused Cognitive Behavioral Therapy for complex presentation (TF-CBT-CP)
EXPERIMENTALThe TF-CBT-CP includes: a) conducting clinical assessment sessions; b) providing psychoeducation on PTSD and CPTSD; c) facilitating the development of coping strategies to manage distressing experiences; d) implementing behavioral activation techniques to reintegrate into daily activities; e) fostering the acquisition of emotional regulation strategies and interpersonal relationship skills; f) utilizing in-vivo (live) and imaginal exposure methods to confront the traumatic memory; g) cognitive work to cope with distorted thoughts, and h) relapse prevention.
Interventions
This TF-CBT-CP is a short-term intervention to treat outpatients. This will be carried out via videoconference.
Eligibility Criteria
You may qualify if:
- Men and women over 18 years of age.
- Referred to a community mental health care service (CMHCS) or hospital in the Maule Region for difficulties associated with the experience of traumatic events, symptomatology, or diagnosis of Post-Traumatic Stress Disorder (PTSD) or Complex Post-Traumatic Stress Disorder (CPTSD).
- Having the diagnosis of Post-Traumatic Stress Disorder (PTSD) or Complex Post-Traumatic Stress Disorder (CPTSD) by International Trauma Interview (ITI).
- Fluent in oral and written Spanish language.
- Access to telephone.
You may not qualify if:
- Previously or currently diagnosed psychotic disorder.
- Current substance use disorder.
- Current suicidal crisis.
- Depression is the primary diagnosis.
- Participation in a PTSD psychological treatment parallel to the study.
- Study's exit criteria:
- Initiation of a psychological or pharmacological treatment for PTSD parallel to the study.
- Change of medication dose in the case of participants with pharmacological treatment prior to the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Talcalead
- Fondo Nacional de Desarrollo Científico y Tecnológico, Chilecollaborator
- Universidad del Desarrollocollaborator
- Universidad Católica del Maulecollaborator
- Servicio de Salud del Maule, Chilecollaborator
Study Sites (5)
Centro Comunitario de Salud Mental de Curicó (COSAM)
Curicó, Maule Region, 3340000, Chile
Centro Comunitario de Salud Mental de Linares (COSAM)
Linares, Maule Region, 3580000, Chile
Hospital de Linares
Linares, Maule Region, 3580000, Chile
Centro Comunitario de Salud Mental de Maule (COSAM)
Maule, Maule Region, 3460000, Chile
Centro Comunitario de Salud Mental de Talca (COSAM)
Talca, Maule Region, 3460000, Chile
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrés Fresno Rodríguez
University of Talca
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Profesor Asociado
Study Record Dates
First Submitted
July 2, 2024
First Posted
July 24, 2024
Study Start
October 22, 2024
Primary Completion (Estimated)
February 28, 2027
Study Completion (Estimated)
March 31, 2027
Last Updated
February 3, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
The approval by the ethics committee did not contemplate the possibility of sharing individual patient data (IPD)